Channel: Mushies
Studies & References Kato K, et al. (2025). *Psilocybin treatment extends cellular lifespan and improves survival of aged mice. npj Aging. Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms. (2026). Pharmacological Research. Uthaug MV, et al. (2026). Pivotal physical states: The somatic equivalent to pivotal mental states. Journal of Psychedelic Studies. MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear. (2026). Biological Psychiatry. Human brain changes after first psilocybin use. (2026). Nature Communications. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.
Recommended






As an Amazon Associate we earn from qualifying purchases.





